Strides get US-FDA approval for Bangalore oncology facility

摘要

Onco Therapies Ltd. (OTL), a division of Agila (a wholly owned subsidiary of Strides) has received approval from the US-FDA for its oncology facility in Bangalore. Consequent to the approval, Strides expects to begin receiving AND A approvals for oncology products for which filings have already been made.